Mafosfamide

DB12083InvestigationalSmall molecule

Mafosfamide has been used in trials studying the treatment of Lymphoma, Leukemia, Meningeal Neoplasm, and Brain and Central Nervous System Tumors.

Chemical structure of Mafosfamide
Formula / weight
C9H19Cl2N2O5PS2 · 401.25 g/mol (avg)

Resolves to

Compound
UNII5970HH9923CAS88859-04-5PubChem76968809
Structure
InChIKeyPBUUPFTVAPUWDE-UGZDLDLSSA-NSMILESOS(=O)(=O)CCS[C@H]1CCO[P@@](=O)(N1)N(CCCl)CCCl

What you can answer from here — as of July 07, 2026

39Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Mafosfamide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In